Used in preclinical research to detect and quantify kidney injury molecule-1 (KIM-1) in mouse models, aiding in the assessment of acute kidney injury (AKI) and nephrotoxicity. Commonly applied in pharmaceutical development to evaluate drug-induced kidney damage, monitor disease progression, and validate therapeutic efficacy in renal studies. Provides a sensitive and specific tool for measuring KIM-1 levels in serum, plasma, and urine samples, supporting biomarker-based kidney health evaluation in experimental settings.